SEC Form 5 · accession 0001570523-18-000003
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 28, 2018 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jan 5, 2017 | P | 100 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 9, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 9, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Jan 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 13, 2017 | P | 200 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 13, 2017 | P | 200 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 17, 2017 | P | 300 | $0.06 | A | 22,059,859 | D | |
| Common stock | Jan 17, 2017 | P | 300 | $0.06 | A | 22,059,859 | D | |
| Common stock | Jan 18, 2017 | P | 200 | $0.06 | A | 22,059,859 | D | |
| Common stock | Jan 20, 2017 | P | 500 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 20, 2017 | P | 200 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jan 23, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 24, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 25, 2017 | P | 1,250 | $0.06 | A | 22,059,859 | D | |
| Common stock | Jan 25, 2017 | P | 4,750 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 25, 2017 | P | 200 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 27, 2017 | P | 100 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 27, 2017 | P | 500 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 27, 2017 | P | 300 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 30, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 30, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 30, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 30, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jan 31, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Feb 6, 2017 | P | 10,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Feb 8, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Feb 10, 2017 | P | 1,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | Feb 10, 2017 | P | 500 | $0.07 | A | 22,059,859 | D | |
| Common stock | Feb 24, 2017 | P | 200 | $0.05 | A | 22,059,859 | D | |
| Common stock | Feb 24, 2017 | P | 200 | $0.05 | A | 22,059,859 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 1 of 16 submissions.